NCT00991718View on ClinicalTrials.gov

A Study of the Hedgehog Pathway Inhibitor GDC-0449 in Healthy Female Subjects of Non-Childbearing Potential

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Healthy
Interventions
DRUG

GDC-0449 oral capsules (non-labeled)

150 mg oral capsule

DRUG

GDC-0449 IV injection (labeled)

10 mcg (in 2 mL) IV dose of 14C-GDC-0449

DRUG

CDC-0449 oral suspension (labeled)

30-mL oral suspension containing 6.5 mcg 14CGDC-0449 and 150 mg GDC-0449

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00991718 - A Study of the Hedgehog Pathway Inhibitor GDC-0449 in Healthy Female Subjects of Non-Childbearing Potential | Biotech Hunter | Biotech Hunter